APA (7th ed.) Citation

GD, P., JP, G., JK, K., RJ, W., WB, L., AC, J., . . . DG, K. (1996). pros-Methylimidazoleacetic acid in cerebrospinal fluid of patients with chronic schizophrenia: Relationships to ratings of symptoms, ventricular brain ratios, and rates of urine excretion. Clinical neuropharmacology, 19(5), 415. https://doi.org/10.1097/00002826-199619050-00004

Chicago Style (17th ed.) Citation

GD, Prell, Green JP, Khandelwal JK, Wyatt RJ, Lawson WB, Jaeger AC, Kaufmann CA, and Kirch DG. "Pros-Methylimidazoleacetic Acid in Cerebrospinal Fluid of Patients with Chronic Schizophrenia: Relationships to Ratings of Symptoms, Ventricular Brain Ratios, and Rates of Urine Excretion." Clinical Neuropharmacology 19, no. 5 (1996): 415. https://doi.org/10.1097/00002826-199619050-00004.

MLA (9th ed.) Citation

GD, Prell, et al. "Pros-Methylimidazoleacetic Acid in Cerebrospinal Fluid of Patients with Chronic Schizophrenia: Relationships to Ratings of Symptoms, Ventricular Brain Ratios, and Rates of Urine Excretion." Clinical Neuropharmacology, vol. 19, no. 5, 1996, p. 415, https://doi.org/10.1097/00002826-199619050-00004.